Z-1338-2019 Class II Terminated
FDA device recall Z-1338-2019 was initiated by Integra Limited on Mar 31, 2019 and is designated Class II. Reason for recall: Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months The recall status is terminated (terminated May 7, 2020). Affected quantity: 274 units.
Recall details
- Product Type
- Devices
- Report Date
- May 22, 2019
- Initiation Date
- Mar 31, 2019
- Termination Date
- May 7, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 274 units
Product description
Integra Flowable Wound Matrix Catalog No: FWD301 Product Usage: Integra Flowable Wound Matrix is indicated for the treatment of tunneling and/or undermined wounds including: surgical wounds (donor sites/grafts, post-Moh s surgery, post-laser surgery, podiatric, wound dehiscence) and diabetic ulcers of both partial and full-thickness varieties. The device is intended for one-time use.
Reason for recall
Stability did not meet acceptance criteria for visual appearance during mixing and force vs. displacement at 6 months
Distribution pattern
Worldwide Distribution - US Nationwide Foreign; Peru, Ecuador, Columbia, Brazil
Code information
Lot Code: 2991332
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1338-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026